Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Agreement with Marubeni Corporation for a Strategic Growth Capital Investment

January 27, 2025

Marubeni to invest in the Sub-Saharan Africa healthcare market as a strategic partner of Phillips Healthcare Corporation, a leading healthcare distributor in Africa.

Phillips Healthcare Corporation (hereinafter, “Phillips Pharma Group”) is pleased to announce that it has entered into an agreement for a strategic growth capital investment by Marubeni Corporation (hereinafter, “Marubeni”).

The investment, which is subject to competition authority approvals, will result in Marubeni becoming a significant minority shareholder in Phillips Pharma Group, in order to support its continued growth and expansion in Sub-Saharan Africa.

Phillips Pharma Group, a leading healthcare distributor with operations in nine countries in Sub- Saharan Africa, markets and distributes a wide range of pharmaceuticals, medical devices and diagnostic equipment from over one hundred of the world’s leading healthcare companies. Marubeni, a leading Japanese integrated trading and investment business conglomerate, will leverage its extensive global network within the healthcare industry to support and facilitate Phillips Pharma Group’s business activities aimed at improving health and wellness in Sub-Saharan Africa.

About Marubeni Corporation

Marubeni Corporation, founded in 1858, headquartered in Japan and listed on the Tokyo Stock Exchange (TYO: 8002), along with its consolidated subsidiaries, use its broad business networks, both within Japan and overseas, to conduct importing and exporting (including third country trading), as well as domestic business, encompassing a diverse range of business activities across wide- ranging fields including lifestyle, ICT business & logistics, food, agribusiness, forest products, chemicals, metals & mineral resources, energy, power, infrastructure project, aerospace & shipping, finance, leasing & real estate business, construction, industrial machinery & mobility, next generation business and corporate development. Additionally, the Marubeni Group offers a variety of services, makes internal and external investments, and is involved in resource development throughout all of the above industries.

Website: https://www.marubeni.com/en/

Leave a Comment